THCV: What It Is, Effects and Safety | PatientsCann UK

THCV

THCV, tetrahydrocannabivarin

pronounced: tet-ruh-hy-droh-kuh-NAB-ih-vair-in

THC’s slimmer cousin - it can dial the CB1 receptor down or up depending on the dose.

Neutral cannabinoidFormula: C19H26O2Intoxicating: Dose-based
Type
Neutral
Formula
C19H26O2
Intoxicating
Dose-based
Key focus
Appetite

Tetrahydrocannabivarin · 286.4 g/mol

The molecule

Chemical structure

This is the accurate skeletal structure of THCV, drawn from PubChem data. Each corner and line-end is a carbon atom, and the red O marks oxygen. Its formula is C19H26O2 and it weighs 286.4 g/mol.

Appetite controlFocusBlood-sugarEnergy

About

What is THCV?

Tetrahydrocannabivarin, or THCV, is a slimmer cousin of THC. It has a shorter carbon "tail", three carbons instead of five, and that small change gives it some surprising behaviour.

THCV is found in higher amounts in certain plants, particularly some varieties from Africa and Asia. At the low doses usually found in products, it is not intoxicating.

In the body

How THCV Works

THCV is unusual because its effect flips with dose. At low doses it blocks the CB1 receptor, the opposite of what THC does, which is why it is being studied to curb appetite. At high doses it can switch CB1 on instead, more like THC. It also acts as a partial activator of CB2.

This double action has made THCV interesting for weight management, and for blood-sugar control in type 2 diabetes, where early trials look promising but are still small.

Receptor snapshot

Where THCV Acts

The endocannabinoid system has two main receptors. Here is how strongly THCV acts on each.

CB1Brain & nervous system
Dampens / blocks

At low doses it BLOCKS CB1 - the opposite of THC - which may curb appetite. At high doses it can switch CB1 on instead.

CB2Immune system & body
Partial

Acts as a partial activator of CB2.

In the plant

How THCV is Made

THCV comes from its acid, THCVA, which sits on a separate "propyl" branch of the family tree. This branch starts from CBGVA, the shorter-tailed version of the mother acid CBGA.

As with the others, heat turns THCVA into THCV.

Comes fromTHCVA→ add heat →THCV

Good to know

Safety and Side Effects

THCV appears well tolerated in early studies, with few side effects at the doses tested. Because it can behave like THC at high doses, very strong products could in theory be intoxicating.

Research in people is still limited, so speak to your prescriber before using THCV, especially if you manage diabetes or take medicines that affect appetite or blood sugar.

Questions

THCV: Common Questions

Is THCV an appetite suppressant?
At low doses THCV blocks the CB1 receptor, the opposite of THC, which is why it is being studied for appetite control and weight management. At high doses this can flip and it may activate CB1 instead.
What makes THCV different from THC?
THCV has a shorter carbon "tail" (three carbons instead of five). This small change flips how it behaves at the CB1 receptor at low doses.
Back to full Cannabinoids Guide
Important: This page is for education only. It is not medical advice. Cannabinoid research is still developing, and many studies have been done in cells or animals rather than people. Always speak to your prescriber before changing your treatment. PatientsCann UK does not recommend any specific cannabis product.

References

  1. Pertwee, R.G. (2008) 'The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta-9-tetrahydrocannabinol, cannabidiol and delta-9-tetrahydrocannabivarin', British Journal of Pharmacology, 153(2), pp. 199-215. doi: 10.1038/sj.bjp.0707442.
  2. Izzo, A.A., Borrelli, F., Capasso, R., Di Marzo, V. and Mechoulam, R. (2009) 'Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb', Trends in Pharmacological Sciences, 30(10), pp. 515-527. doi: 10.1016/j.tips.2009.07.006.
  3. Morales, P., Hurst, D.P. and Reggio, P.H. (2017) 'Molecular targets of the phytocannabinoids: a complex picture', Progress in the Chemistry of Organic Natural Products, 103, pp. 103-131. doi: 10.1007/978-3-319-45541-9_4.
  4. National Center for Biotechnology Information (2025) PubChem Compound Database. Bethesda: U.S. National Library of Medicine. Available at: https://pubchem.ncbi.nlm.nih.gov (Accessed: 29 July 2026).